Skip to Content

ProText Mobility Inc TXTM

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

ProText Mobility Inc is a software application company focusing on the development of pharmaceutical applications for botanical drugs and has the worldwide exclusive license to develop Phytofare in botanical drug applications. The product developed by them is a bioavailable extract produced from live green leaves that have been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract.

Contact
2255 Glades Road
Boca Raton, FL, 33431
T +1 435 881-3611
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2014
Fiscal Year End Dec 31, 2014
Stock Type Distressed
Employees 1